Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Kant Saraogi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Neurovascular Research|April 3, 2026
Nanocarriers in Alzheimer's Therapy: A Comprehensive Review on Nanoparticulate Drug Delivery SystemsAshish Kumar Parashar, Gaurav Kant Saraogi, Vandana Arora Sethi, et al.
Current Drug Delivery|April 1, 2026
Glycosylation in Cancer Medicines Delivery and Their PatentsBiswa Mohan Sahoo, Shikha Sharma, Payal Bhatnagar, et al.
Reviews on Recent Clinical Trials|June 8, 2026
Applications of Artificial Intelligence and Machine Learning in Drug DeliveryAshish Kumar Parashar, Vandana Arora Sethi, Gaurav Kant Saraogi, et al.
Discover Nano|April 29, 2026
Development and evaluation of glycine conjugated polypropyleneimine dendrimers for targeted chloroquine deliveryGaurav Kant Saraogi, Ashish Kumar Parashar, Haya Khader Ahmad Yasin, et al.
International Journal of Pharmaceutics|October 13, 2009
Gelatin nanocarriers as potential vectors for effective management of tuberculosisGaurav Kant Saraogi, Puspa Gupta, U D Gupta, et al.
Discover Oncology|November 11, 2024
Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapyAshish Kumar Parashar, Gaurav Kant Saraogi, Pushpendra Kumar Jain, et al.
Gels (Basel, Switzerland)|February 24, 2022
Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia ManagementGaurav Kant Saraogi, Siddharth Tholiya, Yachana Mishra, et al.
Journal of Drug Targeting|November 27, 2009
Mannosylated nanoparticulate carriers of rifabutin for alveolar targetingNavneet Nimje, Abhinav Agarwal, Gaurav Kant Saraogi, et al.
Journal of Drug Targeting|June 15, 2010
Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosisGaurav Kant Saraogi, Bhavna Sharma, Beenu Joshi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Neurovascular Research|April 3, 2026
Nanocarriers in Alzheimer's Therapy: A Comprehensive Review on Nanoparticulate Drug Delivery SystemsAshish Kumar Parashar, Gaurav Kant Saraogi, Vandana Arora Sethi, et al.
Current Drug Delivery|April 1, 2026
Glycosylation in Cancer Medicines Delivery and Their PatentsBiswa Mohan Sahoo, Shikha Sharma, Payal Bhatnagar, et al.
Reviews on Recent Clinical Trials|June 8, 2026
Applications of Artificial Intelligence and Machine Learning in Drug DeliveryAshish Kumar Parashar, Vandana Arora Sethi, Gaurav Kant Saraogi, et al.
Discover Nano|April 29, 2026
Development and evaluation of glycine conjugated polypropyleneimine dendrimers for targeted chloroquine deliveryGaurav Kant Saraogi, Ashish Kumar Parashar, Haya Khader Ahmad Yasin, et al.
International Journal of Pharmaceutics|October 13, 2009
Gelatin nanocarriers as potential vectors for effective management of tuberculosisGaurav Kant Saraogi, Puspa Gupta, U D Gupta, et al.
Discover Oncology|November 11, 2024
Polymer-drug conjugates: revolutionizing nanotheranostic agents for diagnosis and therapyAshish Kumar Parashar, Gaurav Kant Saraogi, Pushpendra Kumar Jain, et al.
Gels (Basel, Switzerland)|February 24, 2022
Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia ManagementGaurav Kant Saraogi, Siddharth Tholiya, Yachana Mishra, et al.
Journal of Drug Targeting|November 27, 2009
Mannosylated nanoparticulate carriers of rifabutin for alveolar targetingNavneet Nimje, Abhinav Agarwal, Gaurav Kant Saraogi, et al.
Journal of Drug Targeting|June 15, 2010
Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosisGaurav Kant Saraogi, Bhavna Sharma, Beenu Joshi, et al.
Pageof 1